Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: A special reference to classification and predictive factors

Modern Pathology

Volumn 22, Issue 8, 2009, Pages 1102-1112

  Yoon, Sun Och ^a,b,d   Kim, Baek Hui ^c,e   Lee, Hye Seung ^c   Kang, Gyeong Hoon ^b   Kim, Woo Ho ^b   Kim, Young A ^a,b   Kim, Je Eun ^a,b   Chang, Mee Soo ^a,b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

Appendix; B catenin; Mucinous neoplasm; NF kB; P53; Prognosis

Indexed keywords

BETA CATENIN; CARCINOEMBRYONIC ANTIGEN; CYCLIN D1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FRAGILE HISTIDINE TRIAD PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; MUCIN 1; MUCIN 2; MUCIN 5AC; MUCIN 6; PROTEIN BCL 2; PROTEIN MLH1; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN P63; SMAD4 PROTEIN; STEM CELL FACTOR; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN; VASCULOTROPIN;

ADENOMA; ADOLESCENT; ADULT; AGED; APPENDIX CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CELL CYCLE REGULATION; CHILD; COLLOID CARCINOMA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUCINOUS ADENOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APPENDICEAL NEOPLASMS; BETA CATENIN; CHILD; CYSTADENOMA, MUCINOUS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NF-KAPPA B; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 68249087325     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.74     Document Type: Article

References (30)

1. Young RH, Gilks B, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991;15:415-429.
2. Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with multivariate analysis of prognostic factors. Cancer 1995;75:757-768.
3. Misdraji J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms. A clinicopathological analysis of 107 cases. Am J Surg Pathol 2003;27:1089-1103.
4. Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei. Histologic Features, diagnostic problems, and proposed classification. Adv Anat Pathol 2005;12:291-311.
5. Bradley RF, Cortina G, Geisinger KR. Pseudomyxoma peritonei: review of the controversy. Curr Diag Pathol 2007;13:410-416.
6. Carr NJ, Arends MJ, Deans GT, et al. Adenocarcinoma of the appendix. In: Hamilton SR, Aaltonen LA (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, 2000, pp 94-98.
7. Riddel RH, Petras RE, Williams GT, et al. Tumors of the Intestines. Atlas of Tumor Pathology. Third series. Fascicle 32. AFIP: Washinton, DC, 2003, pp 214-247.
8. Day DW, Jass JR, Price AB, et al. Morson and Dawson's Gastrointestinal Pathology, 4th edn, Blackwell Publishing: Oxford, 2003, pp 420-429.
9. Carr NJ, Emory TS, Sobin LH. Epithelial neoplasms of the appendix. In: Odze RD, Goldblum JR, Crawford JM (eds). Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Saunders: Philadelphia, PA, 2004, pp 473-478.
10. Rosai J. Rosai and Ackerman's Surgical Pathology, 9th edn, Mosby: Edinburgh, NY, 2004, pp 757-765.
11. Jass JR. Appendix. In: Fletcher CDM (ed). Diagnostic Histopathology of Tumors, 3rd edn, Churchill Living-stone: London, 2007, pp 390-391.
12. Fenoglio-Preiser, Cecilia M. Gastrointestinal Pathology: An Atlas and Text, 3rd ed, Wolters Kluwer/Lippincott Williams and Wilkins: Philadelphia, 2008, pp 525-541.
13. Leopoldo S, Lorena B, Cinzia A, et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinico-pathological and genetic features. Ann Surg Oncol 2008;15:1429-1439.
14. Tozawa E, Ajioka Y, Watanabe H, et al. Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity? Pathol Res Pract 2007;203:567-574.
15. Arai T, Kasahara I, Sawabe M, et al. Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly: comparison with medullary type poorly differentiated adenocarcinoma. Pathol Int 2007;57:205-212.
16. King-Yin Lam A, Ong K, Ho YH. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum 2006;49:1275-1283.
17. Denkert C, Koch I, von Keyserlingk N, et al. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 2006;19:1261-1269.
18. Li D, Semba S, Wu M, et al. Molecular pathological subclassification of mucinous adenocarcinoma of the colorectum. Pathol Int 2005;55:766-774.
19. Schönleben F, Allendorf JD, Qiu W, et al. Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2008;36:168-172.
20. Miyasaka Y, Nagai E, Yamaguchi H, et al. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2007;13(15 Part 1):4371-4377.
21. Ferreira CR, Carvalho JP, Soares FA, et al. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int J Gynecol Cancer 2008;18:59-65.
22. Yoshida A, Sarian LO, Andrade LA, et al. Cell proliferation activity unrelated to COX-2 expression in ovarian tumors. Int J Gynecol Cancer 2007;17:607-614.
23. Chauhan SC, Singh AP, Ruiz F, et al. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 2006;19:1386-1394.
24. Logan-Collins JM, Lowy AM, Robinson-Smith TM, et al. VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol 2008;15:738-744.
25. Andreopoulou E, Yee H, Warycha MA, et al. Mucinous cancer of the appendix: challenges in diagnosis and treatment. J Chemother 2007;19:451-454.
26. Yajima N, Wada R, Yamagishi S, et al. Immunohisto-chemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix. Hum Pathol 2005;36:1217-1225.
27. Chang MS, Lee HS, Kim WH, et al. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas. Int J Oncol 2005;27:1265-1272.
28. Lee HS, Chang MS, Kim WH, et al. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res 2004;10:1698-1705.
29. Tan PH, Bay BH, Yip G, et al. Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol 2005;18:374-381.
30. Smeenk RM, van Velthuysen ML, Verwaal VJ, et al. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008;34:196-201.